Ask HopeStage to help me review this study
This study may no longer be open, but we can help you understand it and find similar studies.
Study ID: EUCTR 2020-004654-30. We help you review the study, but cannot decide medical eligibility.
Not recruitingEUCTR 2020-004654-30
A Multicenter, Long-Term Open-Label Safety Study of Adjunctive Troriluzole in Subjects with Obsessive Compulsive Disorder
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
OCDDrug
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Check recruitment and locations
EU CTR and CTIS records checked by HopeStage on . Registry information can change. Always confirm availability with the research team.
This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.
View the historical EU CTR record
Historical EU CTR country statuses
- Spain : Ongoing
- Italy : Trial now transitioned
- Netherlands : Ongoing
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
Italy · 4 sites
- ASST Fatebenefratelli Sacco — Department of Biomedical and Clinical Sciences “L. Sacco”MilanCountry status: Not recruiting
- Ospedale San Raffaele S.r.l. — Mood Disorder UnitMilanCountry status: Not recruiting
- Azienda Ospedaliera Universitaria Federico II Di Napoli — Laboratory of Molecular Psychiatry at Department of NeuroscienceNaplesCountry status: Not recruiting
- Azienda Ospedaliero-Universitaria San Luigi Gonzaga — Department of NeurosciencesOrbassanoCountry status: Not recruiting
Spain · 5 sites
- Bellvitge University Hospital — Department of PsychiatryL'hospitalet De LlobregatCountry status: Not recruiting
- Hospital Universitario Ramon Y Cajal — Department of Psychiatry and PsychologyMadridCountry status: Not recruiting
- Hospital Universitario Central De Asturias — Department of PsychiatryOviedoCountry status: Not recruiting
- Hospital Universitario De Salamanca — Department of PsychiatrySalamancaCountry status: Not recruiting
- Hospital Alvaro Cunqueiro — Department of PsychiatryVigoCountry status: Not recruiting
Key information made simple
What the source confirms
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
What should you check before joining?
Check the official protocol for eligibility, treatment, visits and assessments. If recruitment is listed, confirm with the team that a specific centre is still accepting participants before taking any next step.
Your next step
Study sites are listed in the registry. Recruitment status can differ between sites. Ask the research team to confirm the location, any in-person visits, time commitment, costs or compensation, and participation criteria.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Not recruiting
- Enrollment listed in the registry
- 1,200
- Sponsor
- Biohaven Pharmaceuticals, Inc
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Italy, Spain
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2020-004654-30
- Official title
- A Multicenter, Long-Term Open-Label Safety Study of Adjunctive Troriluzole in Subjects with Obsessive Compulsive Disorder
- Official source
- Official registry link
Ask HopeStage to help me review this study
This study may no longer be open, but we can help you understand it and find similar studies.
Study ID: EUCTR 2020-004654-30. We help you review the study, but cannot decide medical eligibility.
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What does the official source confirm?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
Is this study recruiting?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
How can I check the participation requirements?
Check the official protocol for the criteria, treatment and planned assessments. The research team must confirm visits, risks, open centres and your eligibility.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
Not recruitingEUCTR 2020-004653-69
A Randomized, Double-Blind, Placebo-Controlled Trial of Adjunctive Troriluzole in Obsessive Compulsive Disorder
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
CompletedEUCTR 2013-002228-18
A randomized controlled clinical trial for assessing the effectiveness of pharmacogenetic information obtained with NEUROFARMAGEN in the treatment of patients with mental disorders
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
CompletedNCT04693351
Troriluzole for OCD
This study is completed in the United States, in Canada, in the United Kingdom, .... It is testing troriluzole for OCD.